Medication adherence of individuals with a first episode of psychosis
- PMID: 12225495
- DOI: 10.1034/j.1600-0447.2002.02437.x
Medication adherence of individuals with a first episode of psychosis
Abstract
Objective: To determine rates of adherence to antipsychotic medication in first episode patients and the correlates of adherence in this group.
Method: Subjects were the first 200 admissions to an Early Psychosis Program. Adherence was determined on a three-point scale. Symptoms, medication side-effects, quality of life, substance use and family involvement were examined longitudinally.
Results: In their first year in the program 39% were non-adherent, 20% inadequately adherent, and 41% adherent. Non-adherent patients demonstrated more positive symptoms, more relapses, more alcohol and cannabis use, reduced insight, and poorer quality of life. They were younger, had an earlier age of onset and less likely to have a family member involved in treatment.
Conclusion: Results for this group are similar to those reported in the literature. Correlates are often the consequence of non-adherence. Non-compliance has to be anticipated and relationships maintained with patients and families to intervene as soon as possible to minimize the consequence of non-compliance.
Similar articles
-
[Relationships between insight and medication adherence in subjects with psychosis].Encephale. 2003 Sep-Oct;29(5):430-7. Encephale. 2003. PMID: 14615692 French.
-
A prospective evaluation of adherence to medication in first episode schizophrenia.Eur Psychiatry. 2006 Jan;21(1):29-33. doi: 10.1016/j.eurpsy.2005.05.015. Epub 2006 Feb 7. Eur Psychiatry. 2006. PMID: 16460918
-
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.Schizophr Res. 2006 Mar;83(1):53-63. doi: 10.1016/j.schres.2005.10.016. Epub 2006 Mar 9. Schizophr Res. 2006. PMID: 16529910
-
Antipsychotic medication adherence in schizophrenia.Psychiatr Clin North Am. 2007 Sep;30(3):437-52. doi: 10.1016/j.psc.2007.04.002. Psychiatr Clin North Am. 2007. PMID: 17720031 Review.
-
Pharmacotherapy challenges in patients with first-episode psychosis.J Affect Disord. 2012;138 Suppl:S3-14. doi: 10.1016/j.jad.2012.02.029. Epub 2012 Mar 9. J Affect Disord. 2012. PMID: 22405590 Review.
Cited by
-
Treatment adherence with early prescription of long-acting injectable antipsychotics in recent-onset schizophrenia.Schizophr Res Treatment. 2012;2012:368687. doi: 10.1155/2012/368687. Epub 2012 Apr 3. Schizophr Res Treatment. 2012. PMID: 22966435 Free PMC article.
-
Recommendations for the optimal care of patients with recent-onset psychosis in the Asia-Pacific region.Asia Pac Psychiatry. 2016 Jun;8(2):154-71. doi: 10.1111/appy.12234. Asia Pac Psychiatry. 2016. PMID: 27062665 Free PMC article.
-
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample.Schizophr Bull. 2012 Mar;38(2):316-30. doi: 10.1093/schbul/sbq079. Epub 2010 Jul 25. Schizophr Bull. 2012. PMID: 20660494 Free PMC article.
-
Medication adherence in first-episode psychosis and its association with psychopathology.Indian J Psychiatry. 2019;61(4):342-346. doi: 10.4103/psychiatry.IndianJPsychiatry_148_17. Indian J Psychiatry. 2019. PMID: 31391636 Free PMC article.
-
Design paper: The CapOpus trial: a randomized, parallel-group, observer-blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis.Trials. 2008 Jul 11;9:42. doi: 10.1186/1745-6215-9-42. Trials. 2008. PMID: 18620563 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical